Acclarent: Acclarent wins FDA nod for Aera Eustachian tube balloon

Johnson & Johnson (NYSE:JNJ) subsidiary Acclarent said today that it won de novo clearance from the FDA for its Aera Eustachian tube balloon dilation system, designed to treat persistent Eustachian tube dysfunction. The Irvine, Calif.-based company's Aera system consists of a balloon catheter designed to be inserted through the patient's nose into the Eustachian tube. After insertion, the [...]The post Acclarent wins FDA nod for Aera Eustachian tube balloon appeared first on MassDevice.